Trained T-cells to target toxic viruses in pediatric patients

(Children's Hospital Los Angeles) Michael Pulsipher, MD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, along with Michael Keller, MD from Children's National Health System in Washington, DC, have been awarded $4.8 million by the California Institute for Regenerative Medicine (CIRM) to study the use of a new T-cell therapy to help fight active viral infections in children with severe immune deficiencies.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news